Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10
Closed -$745 623
2025
Q4
$745 Buy
+10
New +$731 ﹤0.01% 524
2014
Q1
Sell
-564,735
Closed -$12.6M 377
2013
Q4
$12.6M Sell
564,735
-15,720
-3% -$347K 0.06% 134
2013
Q3
$12M Buy
+580,455
New +$12.4M 0.06% 142

Other funds holding HOLX

Manning & Napier Advisors's HOLX Position: Q1 2026 in Review

Manning & Napier Advisors sold out of Hologic (HOLX) in Q1 2026, closing a stake of 10 shares — an estimated $745 sold.

Manning & Napier Advisors first reported a position in HOLX in Q3 2013 and held it in 3 quarters. The position peaked at $12.6M in Q4 2013. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Manning & Napier Advisors reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • Manning & Napier Advisors sold 10 Hologic shares in Q1 2026, an estimated $745.
  • Manning & Napier Advisors first reported a position in Hologic in Q3 2013 and held it in 3 quarters.
  • Manning & Napier Advisors's Hologic position peaked at $12.6M in Q4 2013.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Manning & Napier Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.